UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact Name of Registrant as Specified in its Charter)
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| |
||||
| (Address of Principal Executive Offices) | (Zip Code) | |||
Registrant’s Telephone Number, Including Area Code:
Not Applicable
(Former Name or Former Address, if Changed Since Last Report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 8.01 | Other Events |
On August 20, 2020, Eli Lilly and Company (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with BNP Paribas Securities Corp., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC, as representatives of the several underwriters named therein, for the issuance and sale by the Company of $850,000,000 in aggregate principal amount of its 2.500% Notes due 2060 (the “2060 Notes”) and $250,000,000 in aggregate principal amount of its 2.250% Notes due 2050 (the “New 2050 Notes” and, together with the 2060 Notes, the “Notes”). Each series of Notes will be issued pursuant to an Indenture (the “Indenture”), dated February 1, 1991, between the Company and Deutsche Bank Trust Company Americas, as successor to Citibank, N.A., as trustee, and an officers’ certificate setting forth the terms of the Notes (including the form of such Notes as an exhibit). The offering of the Notes was registered on a Registration Statement on Form S-3 (File No. 333-229735). The 2060 Notes will accrue interest at a rate of 2.500% per annum, payable semi-annually, and, except as contemplated in the following paragraph, will mature on September 15, 2060. The New 2050 Notes will have the same terms as, and will be treated as the same series with, the $1,000,000,000 in aggregate principal amount of the Company’s 2.250% notes due 2050 issued by the Company under the Indenture on May 5, 2020. Accordingly, the New 2050 Notes will accrue interest at a rate of 2.250% per annum, payable semi-annually, and, except as contemplated in the following paragraph, will mature on May 15, 2050. Upon the issuance of the New 2050 Notes, the outstanding aggregate principal amount of the Company’s 2.250% notes will be $1,250,000,000. Upon the closing of the offering of the Notes, which is expected to occur on August 25, 2020, the Company will realize, after deduction of the underwriting discount and before deduction of offering expenses and excluding accrued interest payable by purchasers of the New 2050 Notes, net proceeds of approximately $1.07 billion.
Upon the occurrence of an Event of Default (as defined in the Indenture) with respect to a series of Notes, the principal amount of the Notes of that series may be declared, and become, immediately due and payable. The Company may, at its election, redeem the Notes, in whole or in part, from time to time at the redemption prices and on the terms and conditions set forth in the Notes.
The above description of the Underwriting Agreement and the Notes is qualified in its entirety by reference to the Underwriting Agreement, the forms of officers’ certificates, the Indenture and the forms of the Notes filed as exhibits hereto, which exhibits are incorporated by reference herein.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits
| * | Incorporated by reference to the same-numbered exhibit of the Company’s Registration Statement on Form S-3 (File No. 333-186979), filed with the Securities and Exchange Commission (“SEC”) on March 1, 2013. |
| ± | Incorporated by reference to the same-numbered exhibit of the Company’s Annual Report on Form 10-K for the year ended December 31, 2008 (File No. 001-06351), filed with the SEC on February 27, 2009. |
| # | Incorporated by reference to the same-numbered exhibit of the Company’s Current Report on Form 8-K (File No. 001-06351), filed with the SEC on April 28, 2020. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| ELI LILLY AND COMPANY | ||
| (Registrant) | ||
| By: | /s/ Crystal T. Williams | |
| Name: | Crystal T. Williams | |
| Title: | Assistant General Counsel and Assistant | |
| Corporate Secretary | ||
| Dated: | August 21, 2020 | |